June 13th 2025
Results show the device significantly improved symptoms of nasal obstruction in patients with nasal septal deviation
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies
View More
Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis
View More
Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
FDA clears TriVerity test to identify and assess acute sepsis and other infections
January 21st 2025The newly approved TriVerity combines a single-use test cartridge and the Myrna instrument to deliver results at the point of care, informing decisions related to antimicrobial therapy, reduce unnecessary hospital admissions and guide patient disposition.
Generative AI in health care: How far do we have to go and what can we do to accelerate progress?
August 23rd 2024Generative AI has a large number of health care use cases, but the road to maturity is a long one. Here is an analysis on AI’s near-term potential in chronic condition management, with thoughts on bias and regulation.